And because one of the things GLP-1 agonists do is slowTrusted Source the emptying of the stomachTrusted Source, past studies also linkTrusted Source GLP-1 agonists to a possible risk of gastroparesis or stomach paralysis
So, it makes me wonder maybe they dont want everybody Plus the money that is made off of type 2 diabetes in this country is a very lucrative business model for many industries
Lifestyle programs without diagnoses will not qualify
It also reduces inflammation and improves insulin sensitivity, enhancing the bodys response to insulin, promoting glucose uptake into cells, as well as reducing the risk of associated metabolic complications
Sarwer, director of the Center for Obesity Research and Education in the Barnett College of Public Health at Temple University, told Flow Space A lot of these things can be multifactorial. With that said, here are seven unusual side effects of GLP-1 drugs
Asian Pacific Journal of Tropical Biomedicine